Please ensure Javascript is enabled for purposes of website accessibility

US Supreme Court Lifts Order That Blocked Trump’s Mass Federal Layoffs

5 hours ago

Trump to Attend Club World Cup Final, FIFA Opens Office in Trump Tower

5 hours ago

Trump Says Pharmaceutical Tariffs Could Reach 200%

5 hours ago

Rescue Teams Find Three More Bodies After Central Texas Floods

5 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Rigoberto Simental Aguilar

6 hours ago

Trump Says He Is Not Happy With Russia’s Putin, Considering Sanctions

6 hours ago

Sean ‘Diddy’ Combs to Be Sentenced on October 3

6 hours ago

Israeli Military Says It Struck Key Hamas Figure in Lebanon’s Tripoli

6 hours ago

Madera County Sheriff Logs 29 Fire-Related Calls on Fourth of July, Most in 5 Years

6 hours ago

Trump Says He May Take Over Governance of Washington, DC

7 hours ago
One-Dose Shot Offers Good Protection, New Hope Against Virus
gvw_ap_news
By Associated Press
Published 4 years ago on
January 29, 2021

Share

Johnson & Johnson’s long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.

J&J said Friday that in the U.S. and seven other countries, the single-shot vaccine was 66% effective overall at preventing moderate to severe illness, and much more protective — 85% — against the most serious symptoms.

There was some geographic variation. The vaccine worked better in the U.S. — 72% effective against moderate to severe COVID-19 – compared to 57% in South Africa, where it was up against an easier-to-spread mutated virus.

“Gambling on one dose was certainly worthwhile,” Dr. Mathai Mammen, global research chief for J&J’s Janssen Pharmaceutical unit, told The Associated Press.

Is Less Protection an Acceptable Trade Off?

With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.

But with some other competing vaccines shown to be 95% effective after two doses, at question is whether somewhat less protection is an acceptable tradeoff to get more shots in arms quickly.

“Frankly, simple is beautiful,” said Dr. Matt Hepburn of Operation Warp Speed, the U.S. government’s vaccine initiative.

The company said within a week, it will file an application for emergency use in the U.S., and then abroad. It expects to supply 100 million doses to the U.S. by June — and a billion doses globally by the end of the year. J&J wouldn’t say exactly how much could be ready to ship as soon as U.S. authorities give the green light.

Study Not Yet Completed

These are preliminary findings from a study of 44,000 volunteers that isn’t completed yet. Researchers tracked illnesses starting 28 days after vaccination – about the time when, if participants were getting a two-dose variety instead, they would have needed another shot.

After day 28, no one who got vaccinated needed hospitalization or died regardless of whether they were exposed to “regular COVID or these particularly nasty variants,” Mammen said. When the vaccinated did become infected, they had a milder illness.

Defeating the scourge that has killed more than 2 million people worldwide will require vaccinating billions, and the shots being rolled out in different countries so far all require two doses a few weeks apart for full protection. Early data is mixed on exactly how well all the different kinds work, but shots made by Pfizer and Moderna appear to be about 95% protective after the second dose.

That makes for a dilemma: Wouldn’t people given a choice want a vaccine found to offer much more protection?

J&J’s Mammen said direct comparisons are difficult because the Pfizer and Moderna vaccines weren’t tested when the pandemic was so severe, with record levels of hospitalizations and deaths plus mutant versions of the virus sweeping some countries.

Dr. Anthony Fauci, the top U.S. infectious disease official, called that a messaging challenge — because the priority is to protect people from hospitalization and death, which J&J’s vaccine appears to do. Especially in places where it’s hard to get people to return for their second dose, the one-dose version could play a key role.

Mutating Virus Creating Challenges

Maybe more important is “a wake-up call” from the study that mutating viruses can challenge vaccines. And the best way to prevent more mutations is “by vaccinating as many people as you possibly can,” Fauci said.

All COVID-19 vaccines train the body to recognize the new coronavirus, usually by spotting the spikey protein that coats it. But they’re made in very different ways.

J&J’s shot uses a cold virus like a Trojan horse to carry the spike gene into the body, where cells make harmless copies of the protein to prime the immune system in case the real virus comes along. It’s the same technology the company used in making a successful Ebola vaccine.

Rival AstraZeneca makes a similar cold virus vaccine that requires two doses. Both the AstraZeneca and J&J vaccines can be stored in a refrigerator, making them easier to ship and to use in developing countries than the frozen kind made by Pfizer and Moderna.

It’s not clear exactly how well the AstraZeneca version, being used in Britain and several other countries, works. Tests in Britain, South Africa and Brazil suggested two doses are about 70% effective although there are questions about how much protection older adults get. An ongoing U.S. study may provide more information.

J&J said its vaccine works consistently in a broad range of people: A third of participants were over age 60, and more than 40% had other illnesses putting them at risk of severe COVID-19, including obesity, diabetes and HIV.

J&J said the vaccine is safe, with reactions similar to other COVID-19 shots such as fever that occur when the immune system is revved up.

Novavax Vaccine Also on Horizon

While it released few details, the company said there were no serious allergic reactions. But occasionally other COVID-19 vaccines trigger such reactions, which can be reversed if promptly treated – and authorities have warned people to be on the lookout regardless of which type of vaccine is used.

J&J had hedged its bets with a study of a two-dose version of its vaccine, which is still underway.

Friday’s interim results come on the heels of another vaccine in final testing. Novavax reported this week that its vaccine appears 89% effective in a U.K. study and that it also seems to work — though not as well — against new mutated versions of the virus circulating in Britain and South Africa. A larger study in the U.S. and Mexico is still enrolling volunteers.

Wall Street appeared dissatisfied with J&J’s results, with shares dropping 4.2% in early trading, a rare big drop for the world’s biggest maker of health care products. Shares were down $4.07, or 2.4%, at $165.09 in mid-morning trading.

In contrast, tiny Novavax saw shares skyrocket, jumping 71% to $229.72 in mid-morning trading.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Fresno Woman Sentenced to Prison for DUI Crash That Killed One, Injured Three

DON'T MISS

Union Files Ethics Complaint After College Chancellor’s ‘Goddaughter’ Receives $161K In Contracts

DON'T MISS

Fresno Police Arrest Suspect Tied to 2 Shootings, Firearm Recovered

DON'T MISS

Are Former Measure C Execs Pushing Their Own Ballot Measure?

DON'T MISS

San Luis Obispo’s Madre Fire Near New Cuyama Grows to 80,615 Acres, 35% Contained

DON'T MISS

US Justice Department Scrambles to Defend Its About-Face on Release of Epstein Files

DON'T MISS

US Supreme Court Lifts Order That Blocked Trump’s Mass Federal Layoffs

DON'T MISS

Trump to Attend Club World Cup Final, FIFA Opens Office in Trump Tower

DON'T MISS

Trump Says Pharmaceutical Tariffs Could Reach 200%

DON'T MISS

Rescue Teams Find Three More Bodies After Central Texas Floods

UP NEXT

TSA Set to Let Airport Travelers Keep Their Shoes on, Media Reports Say

UP NEXT

Space Industry Urges Congress Not to Axe System That Prevents Satellite Collisions

UP NEXT

Rescuers Scour Flood Debris in Texas as Hope Fades for Survivors

UP NEXT

US Veterans Affairs Will Cut Nearly 30,000 Jobs, Far Fewer Than Planned

UP NEXT

US Proposes Rules That Could Boost Oil, Gas Output in US West

UP NEXT

Man Dead After Firing at US Border Patrol Station in Texas

UP NEXT

Texas Girls’ Camp Mourning Dozens Dead in Floods as Search Teams Face More Rain

UP NEXT

Death Toll From Texas Floods Reaches 78, Trump Plans Visit

UP NEXT

Death Toll From Texas Floods Reaches 59, Including 21 Children

UP NEXT

Fresno Crash Involving Unlicensed Teen Driver Sends Woman to Hospital

Are Former Measure C Execs Pushing Their Own Ballot Measure?

3 hours ago

San Luis Obispo’s Madre Fire Near New Cuyama Grows to 80,615 Acres, 35% Contained

4 hours ago

US Justice Department Scrambles to Defend Its About-Face on Release of Epstein Files

4 hours ago

US Supreme Court Lifts Order That Blocked Trump’s Mass Federal Layoffs

5 hours ago

Trump to Attend Club World Cup Final, FIFA Opens Office in Trump Tower

5 hours ago

Trump Says Pharmaceutical Tariffs Could Reach 200%

5 hours ago

Rescue Teams Find Three More Bodies After Central Texas Floods

5 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Rigoberto Simental Aguilar

6 hours ago

Trump Says He Is Not Happy With Russia’s Putin, Considering Sanctions

6 hours ago

Sean ‘Diddy’ Combs to Be Sentenced on October 3

6 hours ago

Fresno Woman Sentenced to Prison for DUI Crash That Killed One, Injured Three

A 23-year-old Fresno woman was sentenced Tuesday to more than a decade in state prison for a 2021 drunk driving crash that killed one passen...

37 minutes ago

37 minutes ago

Fresno Woman Sentenced to Prison for DUI Crash That Killed One, Injured Three

1 hour ago

Union Files Ethics Complaint After College Chancellor’s ‘Goddaughter’ Receives $161K In Contracts

Jershawn Worthy was identified as the suspect in two Fresno shootings and is now facing multiple firearm-related charges. (Fresno PD)
2 hours ago

Fresno Police Arrest Suspect Tied to 2 Shootings, Firearm Recovered

3 hours ago

Are Former Measure C Execs Pushing Their Own Ballot Measure?

The Madre Fire near New Cuyama has burned more than 80,615 acres, injured one firefighter, and prompted multiple evacuation orders as crews work to contain the growing wildfire. (CalFire)
4 hours ago

San Luis Obispo’s Madre Fire Near New Cuyama Grows to 80,615 Acres, 35% Contained

U.S. financier Jeffrey Epstein appears in a photograph taken for the New York State Division of Criminal Justice Services' sex offender registry March 28, 2017 and obtained by Reuters July 10, 2019. New York State Division of Criminal Justice Services/Handout via REUTERS/File Photo
4 hours ago

US Justice Department Scrambles to Defend Its About-Face on Release of Epstein Files

A general view of the U.S. Supreme Court building in Washington, U.S., June 1, 2024. (Reuters File)
5 hours ago

US Supreme Court Lifts Order That Blocked Trump’s Mass Federal Layoffs

President Donald Trump holds the key to the FIFA Club World Cup trophy in the Oval Office of the White House in Washington, D.C., U.S., March 7, 2025. (Reuters File)
5 hours ago

Trump to Attend Club World Cup Final, FIFA Opens Office in Trump Tower

Help continue the work that gets you the news that matters most.

Search

Send this to a friend